After receiving several COVID-19 vaccines, a variety of menstrual disorders, including heavy or prolonged bleeding, irregular intervals, and increased pain appear, according to the Norwegian study.
According to an initial report from a major population study, nearly twice as many young Norwegian women had a heavier menstrual period than they were used to after having their COVID-19 shots.
The National Institute of Public Health (FHI) in Norway is currently conducting a large study with over 60,000 girls and women aged 12-80 to see if there is a link between COVID-19 shots and various bleeding disorders. Preliminary results for the 6,000 women in the 18-30 age bracket have been revealed so far.
“We see in this study that a number of women experienced various disorders after the first or second dose of the COVID vaccine”, project manager FHI doctor Lill Trogstad said in a press release.
The proportion of women reporting significant bleeding has increased from 7.6% before vaccination to 13.6 per cent after vaccination. After the second shot, their share grew to 15.3 per cent.
Prolonged bleeding, unusually short or long intervals, unexpected intermitted internal bleeding, extra painful periods, or even menstrual discomfort without bleeding were all common complaints.
Pfizer was provided to 59.4 per cent of the patients as their first dose, followed by Moderna, 4.7 per cent AstraZeneca, and 0.2 per cent Janssen (Johnson & Johnson). For dose two, 47.4 per cent received Pfizer and 52.6 per cent Moderna.
Source: Sputnik News